Navigation Links
Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe
Date:11/10/2008

Hands-On Science Research Program Expansion Brings the Amgen Foundation's

Total Commitment to Amgen Scholars to $27.5 Million

Applications for 2009 Amgen Scholars U.S. Program Now Available

THOUSAND OAKS, Calif., Nov. 10 /PRNewswire/ -- Each year, hundreds of students from across the United States (U.S.) participate in the Amgen Scholars Program under renowned faculty members at the country's leading universities. Now, the same opportunity will be extended to undergraduates throughout Europe. As part of its mission to advance science education, the Amgen Foundation, in partnership with three of Europe's leading universities, today announced the launch of the Amgen Scholars Program in Europe.

"With the launch of the Amgen Scholars Program in Europe, undergraduates from many nations will have the opportunity to immerse themselves in the real world of research and experience firsthand what it takes to contribute to the advancement of knowledge," said Jean J. Lim, president of the Amgen Foundation. "Under the guidance of distinguished faculty mentors, we hope the Scholars will be inspired to discover their potential as future scientists."

The initial expansion of Amgen Scholars to Europe is a $2.5 million, two-year program that will provide research experience for students interested in pursuing a graduate degree and a career in science. The three European university partners are the University of Cambridge in the United Kingdom, Karolinska Institutet in Sweden and Ludwig-Maximilians-Universitat Munchen in Germany.

For the first phase of the program, which extends through 2010, each of the three university partners will receive funding to host the summer research program, selecting undergraduate participants from colleges and universities across Europe. Similar to the Amgen Scholars U.S. Program, students will participate in an annual three-day symposium where they will hear firsthand from leading scientists working in industry and academia.

Internationally renowned Cambridge University will serve as the European Coordinating Center and will play a leading role in providing coordination, technical oversight and student outreach for the program, in addition to hosting the annual Amgen Scholars European Symposium.

"The Amgen Scholars Program will provide undergraduate students from across Europe with a fantastic opportunity to experience the scientific discovery process, as well as to network with top scientists and industry leaders," said Professor Tony Minson, Pro-Vice Chancellor of the University of Cambridge and the Director of the Amgen Scholars European Coordinating Center. "We hope that this will inspire more young people to consider scientific careers -- at a time when the education of the next generation of scientists is more important than ever."

2009 Amgen Scholars U.S. Program Applications Now Available

The Amgen Scholars U.S. Program, a $25 million, eight-year commitment of the Amgen Foundation, in partnership with 10 of the nation's premier universities, is now accepting applications for the summer of 2009. In 2007, the program's first year, 238 undergraduate students were selected as Amgen Scholars from approximately 1,700 applicants from across the U.S. In 2008, applicants rose to nearly 2,400 and nearly 250 students, representing 120 different U.S. colleges and universities, were chosen to participate.

The opportunity to work with some of the leading academic scientists in the country is a cornerstone of the program, with participating universities seeking to match students with faculty members who will both inspire and challenge them. For example, Dr. Martin Chalfie of Columbia University, one of the 2008 Nobel Prize recipients in Chemistry for the discovery and development of the green fluorescent protein, GFP, mentored an Amgen Scholar in his lab at Columbia.

Amgen Foundation's 10 host universities for the Amgen Scholars U.S. Program are California Institute of Technology; Columbia University/Barnard College; Howard University; Massachusetts Institute of Technology; Stanford University; University of California, Berkeley; University of California, Los Angeles; University of California, San Diego; University of California, San Francisco; and University of Washington. MIT, which has long been at the forefront of undergraduate research programming, serves as the U.S. Program Office and plays a leading role in the coordination, technical oversight and student outreach for the program.

Each of the 10 participating host universities in the U.S. is responsible for selecting approximately 25 participants from both their own student body, as well as from other accredited four-year colleges or universities in the U.S., Puerto Rico or other U.S. territories.

Financial support for students is a critical component of the U.S. and European program, which aims to ensure that eligible students, regardless of their financial status, are able to participate. Please note that details vary by host university.

For more information about Amgen Scholars including eligibility criteria and applications, please visit http://www.amgenscholars.com.

About the Amgen Foundation

The Amgen Foundation (http://www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. Since 1991, the Foundation has made more than $125 million in grants to nonprofit organizations throughout the United States, Puerto Rico and Europe that impact society in inspiring and innovative ways. It has also supported disaster relief efforts both domestically and internationally.

Contacts

Kristen Davis, (805) 447-3008 (U.S. media)

Annette Condon, +353 87 284 1951 (EU media)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Amgen Positioned to Deliver Attractive Growth Over Next Five Years
2. Amgen to Webcast 2008 Business Review Meeting on November 7 From Millennium Hotel in New York
3. Call for Applications: The Amgen Award for Science Teaching Excellence
4. Amgens Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23
5. Amgen Announces Webcast of 2008 Third Quarter Financial Results
6. Co-Inventor of Amgens Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals First-in-Class Oxygen Enhancing Therapeutics
7. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
8. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
9. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
10. More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation
11. Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... Spyker, PhD, MD former Acting Deputy Director in the FDA CDRH Division of ... Staff has joined the company as an Expert Consultant. , In Dr. Spyker’s ...
(Date:2/21/2017)... , Feb. 21, 2017 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or ... operational results for the three months ended December 31, 2016. ... -based life sciences and diagnostics company that develops and commercializes ... ... to build on the commercial milestones achieved in fiscal 2016," ...
(Date:2/21/2017)... ... February 21, 2017 , ... The medical potential of stem cells is both ... of medicine, due to their differentiating characteristics. Stem cells are unique as the have ... be induced to become tissue or organic-specific cells with special functions. , Stem ...
(Date:2/21/2017)... 2017  Lexus, a returning partner of the Amgen Tour ... exclusive automobile partner of the men,s and women,s events for the ... 2017 Amgen Tour of California will mark ... the best professional cycling teams in the world racing from Northern ... Amgen Breakaway from Heart Disease TM Women,s Race ...
Breaking Biology Technology:
(Date:2/3/2017)... , Feb. 3, 2017 A new independent ... Strategy Partners, LLP (IdSP) . Designed to fill a ... complex identity market, founding partners Mark Crego ... combined years just in identity expertise that span federal ... non-profit leadership. The Crego-Kephart combined expertise has a common ...
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
(Date:1/24/2017)... Jan. 24, 2017 Biopharm Reports has ... laboratory use of nuclear magnetic resonance spectroscopy (NMR). ... and profiled current practices, developments, trends and end-user ... as growth and opportunities. These areas include growth ... instruments, needs and innovation requirements, hyphenated NMR techniques, ...
Breaking Biology News(10 mins):